Expression and function of TβRII-B, a variant of the type II TGF-β receptor, in human chondrocytes

Osteoarthritis and Cartilage

Volumn 15, Issue 4, 2007, Pages 442-453

  Parker, W L ^a   Finnson, K W ^a   Soe Lin, H ^a   Knaus, P ^b   Philip, A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Cartilage; Chondrocytes; Osteoarthritis; T RII B; TGF receptors

Indexed keywords

COLLAGEN TYPE 2; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2 B; UNCLASSIFIED DRUG; TGFBR2 PROTEIN, HUMAN;

ADULT; ARTICLE; CARTILAGE; CARTILAGE CELL; CELL LINE; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; LIGAND BINDING; OSTEOARTHRITIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ARTICULAR CARTILAGE; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 33847736357     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2006.10.006     Document Type: Article

References (55)

1. Van den Berg W.B. From cartilage metabolism to clinics: the role of cytokines and growth factors in cartilage destruction in osteoarthritis and rheumatoid arthritis. J Rheumatol 58 (1999) 136-141
2. Grimaud E., Heymann D., and Redini F. Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. Cytokine Growth Factor Rev 13 (2002) 241-257
3. Scharstuhl A., Glansbeek H.L., van Beuningen H.M., Vitters E.L., van der Kraan P.M., and van den Berg W.B. Inhibition of endogenous TGF-beta during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol 169 (2002) 507-514
4. Serra R., Johnson M., Filvaroff E.H., LaBorde J., Sheehan D.M., Derynck R., et al. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139 (1997) 541-552
5. Yang X., Chen L., Xu X., Li C., Huang C., and Deng C.X. TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 153 (2001) 35-46
6. Itayem R., Mengarelli-Widholm S., and Reinholt F.P. The long-term effect of a short course of transforming growth factor-beta1 on rat articular cartilage. Apmis 107 (1999) 183-192
7. van Beuningen H.M., Glansbeek H.L., van der Kraan P.M., and van den Berg W.B. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 8 (2000) 25-33
8. Roberts A.B., and Sporn M.B. In: Sporn M.B., and Roberts A.B. (Eds). Peptide Growth Factors and Their Receptors (1990), Springer-Verlag, New York, NY 419-472
9. Seyedin S.M., Thompson A.Y., Bentz H., Rosen D.M., McPherson J.M., Conti A., et al. Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J Biol Chem 261 (1986) 5693-5695
10. Shi Y., and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
11. ten Dijke P., and Hill C.S. New insights into TGF-beta-Smad signalling. Trends Biochem Sci 9 (2004) 265-273
12. Hirai R., and Fujita T. A human transforming growth factor-b type II receptor that contains an insertion in the extracellular domain. Exp Cell Res 223 (1996) 135-141
13. Lopez-Casillas F., Wrana J.L., and Massague J. Betaglycan presents ligand to the TGF beta signaling receptor. Cell 73 (1993) 1435-1444
14. Philip A., Hannah R., and O'Connor-McCourt M. Ectodomain cleavage and shedding of the type III transforming growth factor-beta receptor in lung membranes effect of temperature, ligand binding and membrane solubilization. Eur J Biochem 261 (1999) 618-628
15. Yamashita H., Ichijo H., Grimsby S., Moren A., ten Dijke P., and Miyazono K. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta. J Biol Chem 269 (1994) 1995-2001
16. Letamendia A., Lastres P., Botella L.M., Raab U., Langa C., Velasco B., et al. Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan. J Biol Chem 273 (1998) 33011-33019
17. Guerrero-Esteo M., Sanchez-Elsner T., Letamendia A., and Bernabeu C. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. J Biol Chem 277 (2002) 29197-29209
18. Brown C.B., Boyer A.S., Runyan R.B., and Barnett J.V. Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science 283 (1999) 2080-2082
19. Sankar S., Mahooti-Brooks N., Centrella M., McCarthy T.L., and Madri J.A. Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor beta 2. J Biol Chem 270 (1995) 13567-13572
20. Rotzer D., Roth M., Lutz M., Lindemann D., Sebald W., and Knaus P. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor. EMBO J 20 (2001) 480-490
21. del Re E., Babitt J.L., Pirani A., Schneyer A.L., and Lin H.Y. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2. J Biol Chem 279 (2004) 22765-22772
22. Parker W.L., Goldring M.B., and Philip A. Endoglin is expressed on human chondrocytes and forms a heteromeric complex with betaglycan in a ligand and type II TGFbeta receptor independent manner. J Bone Miner Res 18 (2003) 289-302
23. Piek E., Franzen P., Heldin C.H., and ten Dijke P. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding. J Cell Physiol 173 (1997) 447-459
24. Nakao A., Imamura T., Souchelnytskyi S., Kawabata M., Ishisaki A., Oeda E., et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16 (1997) 5353-5362
25. Souchelnytskyi S., Ronnstrand L., Heldin C.H., and ten Dijke P. Phosphorylation of Smad signaling proteins by receptor serine/threonine kinases. Methods Mol Biol 124 (2001) 107-120
26. Hollander A.P., Heathfield T.F., Webber C., Iwata Y., Bourne R., Rorabeck C., et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 93 (1994) 1722-1732
27. Goldring M.B., Birkhead J.R., Suen L.-F., Yamin R., Mizuno S., Glowacki J., et al. Successful immortalization of human chondrocytes exhibiting stable expression of cartilage-specific type II collagen. J Clin Invest 94 (1994) 2307-2316
28. Robbins J.R., and Goldring M.B. In: Morgan J.R., and Yarmush M. (Eds). Methods in Molecular Medicine (1997), Humana Press Inc., Totowa, NJ 173-192
29. Chanda V.B. In: Chanda V.B. (Ed). Current Protocols in Molecular Biology, Supplement (1995), John Wiley and Sons, Canada 8-10
30. Gruppuso P.A., Mead J.E., and Fausto N. Transforming growth factor receptors in liver regeneration following partial hepatectomy in the rat. Cancer Res 50 (1990) 1464-1469
31. Lin H.Y., Wang X.F., Ng-Eaton E., Weinberg R.A., and Lodish H.F. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 68 (1992) 775-785
32. Wong S.H., Hamel L., Chevalier S., and Philip A. Endoglin expression on human microvascular endothelial cells association with betaglycan and formation of higher order complexes with TGF-beta signalling receptors. Eur J Biochem 267 (2000) 5550-5560
33. Glick A.B., Danielpour D., Morgan D., Sporn M.B., and Yuspa S.H. Induction and autocrine receptor binding of transforming growth factor-beta 2 during terminal differentiation of primary mouse keratinocytes. Mol Endocrinol 4 (1990) 46-52
34. MacKay K., Robbins A.R., Bruce M.D., and Danielpour D. Identification of disulfide-linked transforming growth factor-beta 1-specific binding proteins in rat glomeruli. J Biol Chem 265 (1990) 9351-9356
35. Wrana J.L., Attisano L., Wieser R., Ventura F., and Massague J. Mechanism of activation of the TGF-beta receptor. Nature 370 (1994) 341-347
36. Finnson K.W., Tam B.Y., Liu K., Marcoux A., Lepage P., Roy S., et al. Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes. FASEB J 20 (2006) 1525-1527
37. Goldring M.B., and Berenbaum F. Human chondrocyte culture models for studying cyclooxygenase expression and prostaglandin regulation of collagen gene expression. Osteoarthritis Cartilage 7 (1999) 386-388
38. Kokenyesi R., Tan L., Robbins J.R., and Goldring M.B. Proteoglycan production by immortalized human chondrocyte cell lines cultured under conditions that promote expression of the differentiated phenotype. Arch Biochem Biophys 383 (2000) 79-90
39. Loeser R.F., Sadiev S., Tan L., and Goldring M.B. Integrin expression by primary and immortalized human chondrocytes: evidence of a differential role for alpha1beta1 and alpha2 beta1 integrins in mediating chondrocyte adhesion to types II and VI collagen. Osteoarthritis Cartilage 8 (2000) 96-105
40. Robbins J.R., Thomas B., Tan L., Choy B., Arbiser J.L., Berenbaum F., et al. Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1beta. Arthritis Rheum 43 (2000) 2189-2201
41. Letamendia A., Lastres P., Almendro N., Raab U., Buhring H.J., Kumar S., et al. Endoglin, a component of the TGF-beta receptor system, is a differentiation marker of human choriocarcinoma cells. Int J Cancer 76 (1998) 541-546
42. Piek E., Ju W.J., Heyer J., Escalante-Alcalde D., Stewart C.L., Weinstein M., et al. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem 276 (2001) 19945-19953
43. Choy L., Skillington J., and Derynck R. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J Cell Biol 149 (2000) 667-682
44. Glansbeek H.L., van der Kraan P.M., Lafeber F.P., Vitters E.L., and van den Berg W.B. Species-specific expression of type II TGF-beta receptor isoforms by articular chondrocytes: effect of proteoglycan depletion and aging. Cytokine 9 (1997) 347-351
45. Lebrin F., Goumans M.J., Jonker L., Carvalho R.L., Valdimarsdottir G., Thorikay M., et al. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J 23 (2004) 4018-4028
46. Anders R.A., Arline S.L., Dore J.J., and Leof E.B. Distinct endocytic responses of heteromeric and homomeric transforming growth factor beta receptors. Mol Biol Cell 8 (1997) 2133-2143
47. Chen R.H., Moses H.L., Maruoka E.M., Derynck R., and Kawabata M. Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-beta receptors. J Biol Chem 270 (1995) 12235-12241
48. Ventura F., Doody J., Liu F., Wrana J.L., and Massague J. Reconstitution and transphosphorylation of TGF-beta receptor complexes. EMBO J 13 (1994) 5581-5589
49. Feng X.H., and Derynck R. Ligand-independent activation of transforming growth factor (TGF) beta signaling pathways by heteromeric cytoplasmic domains of TGF-beta receptors. J Biol Chem 271 (1996) 13123-13129
50. Wells R.G., Gilboa L., Sun Y., Liu X., Henis Y.I., and Lodish H.F. Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells. J Biol Chem 274 (1999) 5716-5722
51. Abdalla S.A., Pece-Barbara N., Vera S., Tapia E., Paez E., Bernabeu C., et al. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Hum Mol Genet 9 (2000) 1227-1237
52. Derynck R., and Feng X.H. TGF-beta receptor signaling. Biochim Biophys Acta 1333 (1997) F105-F150
53. Gilboa L., Nohe A., Geissendorfer T., Sebald W., Henis Y.I., and Knaus P. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell 11 (2000) 1023-1035
54. Engel M.E., McDonnell M.A., Law B.K., and Moses H.L. Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem 274 (1999) 37413-37420
55. Wrana J.L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M., et al. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71 (1992) 1003-1014